Pembroke Pines, FL2 Active Studies

Atrial Fibrillation Clinical Trials in Pembroke Pines, FL

Find 2 actively recruiting atrial fibrillation clinical trials in Pembroke Pines, FL. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
300
Enrolling

Recruiting Atrial Fibrillation Studies in Pembroke Pines

About Atrial Fibrillation Clinical Trials in Pembroke Pines

Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.

There are currently 2 atrial fibrillation clinical trials recruiting participants in Pembroke Pines, FL. These studies are seeking a combined 300 participants. Research is being sponsored by Incyte Corporation, Cynata Therapeutics Limited. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atrial Fibrillation Clinical Trials in Pembroke Pines — FAQ

Are there atrial fibrillation clinical trials in Pembroke Pines?

Yes, there are 2 atrial fibrillation clinical trials currently recruiting in Pembroke Pines, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Pembroke Pines?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Pembroke Pines research site will contact you about next steps.

Are clinical trials in Pembroke Pines free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Pembroke Pines studies also compensate for your time and travel.

What atrial fibrillation treatments are being tested?

The 2 active trials in Pembroke Pines are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.

Data updated March 2, 2026 from ClinicalTrials.gov